利索-全球专利检索

  1. 登录
  2. 注册

搜索结果

12 条记录 (耗时 0.03 秒)

    Antiviral substituted pyrimidinedione homocarbocyclic nucleoside derivatives and methods for the preparation thereof and compositions containing the same as active ingredients
    1.
    发明授权
    Antiviral substituted pyrimidinedione homocarbocyclic nucleoside derivatives and methods for the preparation thereof and compositions containing the same as active ingredients 失效
    抗病毒取代的嘧啶二酮同型碳环核苷衍生物及其制备方法和含有活性成分的组合物

    公开(公告)号：US5922727A

    公开(公告)日：1999-07-13

    申请号：US945121

    申请日：1998-01-21

    申请人： Eui-Hwan Cho ,  Sun-Gan Chung ,  Joong-Young Kim ,  Sun-Hwan Lee ,  Ho-Seok Kwon ,  Jae-Eung Lee ,  Jeong-Ho Joo ,  Byung-Chul Kim ,  Dong-Wook Kang

    发明人： Eui-Hwan Cho ,  Sun-Gan Chung ,  Joong-Young Kim ,  Sun-Hwan Lee ,  Ho-Seok Kwon ,  Jae-Eung Lee ,  Jeong-Ho Joo ,  Byung-Chul Kim ,  Dong-Wook Kang

    IPC分类号： A61K31/505 ,  A61K31/506 ,  A61K31/695 ,  A61P31/12 ,  A61P31/14 ,  A61P31/18 ,  C07D239/54 ,  C07D239/60

    CPC分类号： C07D239/54 ,  C07D239/60

    摘要： The present invention relates to novel compound of general formula (I) and pharmaceutically acceptable salts thereof, and process for the preparation of such derivatives and to pharmaceutical compositions containing the same as active ingredients. ##STR1## wherein R.sub.1, R.sub.2, and R.sub.3 represents independently hydrogen atom, halogen atom, C.sub.1 -C.sub.10 alkyl, C.sub.1 -C.sub.10 thioalkyl, C.sub.3 -C.sub.8 optionally substituted cyclicalkyl, unsaturated alkyl, substituted alkyl hydroxyl or aryl hydroxyl, C.sub.1 -C.sub.10 alkylamine, nitro, C.sub.1 -C.sub.4 lower ester, C.sub.1 -C.sub.4 lower alkoxy, C.sub.1 -C.sub.4 lower thioalkoxy; Z represents oxygen atom, sulfur atom, carbon atom and carbonyl group; X represents oxygen atom, sulfur atom; n represents an integer of 1-3; and (sub)cycloalk(en)yl represents ##STR2## in which R.sub.4 and R.sub.5 represents independently hydrogen atom, hydroxymethyl, protected hydroxymethyl, benzyl, substituted carbonyl, substituted alkylsulfonyl or arylsulfonyl, substituted silyl or the like.

    摘要翻译： PCT No.PCT / KR96 / 00265 Sec。 371日期1998年1月21日 102（e）1998年1月21日PCT PCT 1996年12月30日PCT公布。 公开号WO97 / 30979 日期：1997年8月28日本发明涉及通式（I）的新型化合物及其药学上可接受的盐，以及制备该衍生物的方法以及含有活性成分的药物组合物。 其中R1，R2和R3独立地表示氢原子，卤素原子，C1-C10烷基，C1-C10硫代烷基，C3-C8任意取代的环烷基，不饱和烷基，取代的烷基羟基或芳基羟基，C1-C10烷基胺，硝基，C1 -C4低级酯，C1-C4低级烷氧基，C1-C4低级硫代烷氧基; Z表示氧原子，硫原子，碳原子和羰基; X表示氧原子，硫原子; n表示1-3的整数; 和（亚）环烷基（en）代表其中R 4和R 5独立地表示氢原子，羟甲基，保护的羟甲基，苄基，取代的羰基，取代的烷基磺酰基或芳基磺酰基，取代的甲硅烷基等。

    Piperazine derivatives and process for the preparation thereof
    2.
    发明授权
    Piperazine derivatives and process for the preparation thereof 失效

    公开(公告)号：US6028195A

    公开(公告)日：2000-02-22

    申请号：US29660

    申请日：1998-02-27

    申请人： Eui-Hwan Cho ,  Sun-Gan Chung ,  Sun-Hwan Lee ,  Ho-Seok Kwon ,  Jae-Eung Lee ,  Dong-Wook Kang ,  Jeong-Ho Joo ,  Young-Hee Lee

    发明人： Eui-Hwan Cho ,  Sun-Gan Chung ,  Sun-Hwan Lee ,  Ho-Seok Kwon ,  Jae-Eung Lee ,  Dong-Wook Kang ,  Jeong-Ho Joo ,  Young-Hee Lee

    IPC分类号： C07D295/104 ,  A61K31/44 ,  A61K31/47 ,  A61K31/495 ,  A61P35/00 ,  C07D213/74 ,  C07D213/75 ,  C07D215/38 ,  C07D221/04 ,  C07D295/112 ,  C07D295/215 ,  C07D401/04 ,  C07D409/04 ,  C07D401/12

    CPC分类号： C07D213/75 ,  C07D215/38 ,  C07D221/04 ,  C07D295/215 ,  C07D401/04 ,  C07D409/04 ,  Y02P20/582

    摘要： The present invention relates to novel compound having strong antimumor activities of the general formula(I) ##STR1## wherein R.sub.1 and R.sub.2 are independently hydrogen, substituted or unsubstituted C.sub.1 -C.sub.8 alkyl, substituted or unsubstituted C.sub.3 -C.sub.6 cycloalkyl, substituted or unsubstituted C.sub.2 -C.sub.8 unsaturated alkyl, ketone, substituted or unsubstituted aryl, substituted or unsubstituted C.sub.1 -C.sub.4 alkoxy, substituted or unsubstituted arylhydroxy, substituted or unsubstituted amino, C.sub.1 -C.sub.4 lower ester, C.sub.1 -C.sub.4 lower thioester, thiol, substituted or unsubstituted carboxyl, epoxy, substituted or unsubstituted C.sub.1 -C.sub.4 lower thioalkoxy; or R.sub.1 and R.sub.2 are fused to form C.sub.3 -C.sub.4 saturated or unsaturated chain; R.sub.3, R.sub.4, R.sub.5, R.sub.6 and R.sub.7 are independently hydrogen, halogen, hydroxy, nitro, C.sub.1 -C.sub.4 lower ester, C.sub.1 -C.sub.4 lower alkyl, C.sub.1 -C.sub.4 lower thioalkyl, substituted or unsubstituted C.sub.3 -C.sub.6 cycloalkyl, C.sub.1 -C.sub.4 lower alkoxy, C.sub.1 -C.sub.4 lower thioalkoxy, substituted or unsubstituted aryl, substituted or unsubstituted lower arylalkoxy, substituted or unsubstituted lower alkylamino, or lower alkyl substituted or unsubstituted carbamate; or among R.sub.3, R.sub.4, R.sub.5, R.sub.6 and R.sub.7, two adjacent groups are bonded with each other to form 1,2-phenylene or 2,3-naphthylene; X is oxygen, sulfur, or substituted or unsubstituted imino; Y is bonded at the 3-position or 4-position of the aromatic ring part wherein Y is oxygen or --NR.sub.8 -- (wherein, R.sub.8 is the same with the above-mentioned R.sub.3.); Z is hydroxy, C.sub.1 -C.sub.4 lower alkoxy, C.sub.1 -C.sub.4 lower thioalkoxy, substituted or unsubstituted aryloxy, C.sub.1 -C.sub.4 lower alkylamino, substituted or unsubstituted cycloamino containing 1-5 nitrogen atoms; A is nitrogen or --CH.dbd.; its pharmaceutically acceptable acid addition salts and process for the preparation thereof.

    Antiviral pyrimidinedione derivatives and process for the preparation thereof
    3.
    发明授权
    Antiviral pyrimidinedione derivatives and process for the preparation thereof 失效
    抗病毒嘧啶二酮衍生物及其制备方法

    公开(公告)号：US06987114B1

    公开(公告)日：2006-01-17

    申请号：US09719282

    申请日：2000-04-08

    申请人： Eui-Hwan Cho ,  Sun-Gan Chung ,  Sun-Hwan Lee ,  Ho-Seok Kwon ,  Jae-Eung Lee ,  Jeong-Ho Joo

    发明人： Eui-Hwan Cho ,  Sun-Gan Chung ,  Sun-Hwan Lee ,  Ho-Seok Kwon ,  Jae-Eung Lee ,  Jeong-Ho Joo

    IPC分类号： C07D239/54 ,  C07D239/60 ,  A61K31/513

    CPC分类号： C07D239/54 ,  C07D239/60 ,  C07D401/06 ,  C07D403/06 ,  C07D405/06 ,  C07D413/06

    摘要： The present invention relates to pyrimidinedione derivatives of following formula (I) which are useful as antiviral agents, especially as agents for treatment of AIDS, pharmaceutically acceptable salts thereof, process for the preparation thereof and pharmaceutical compositions containing the same, wherein R represents cyclopropyl; cyclobutyl; cyclohexyl; unsubstituted or mono-, di- or trisubstituted phenyl with a group selected from hydroxy, C1–C4 alkyl, C1–C4 alkoxy, halogen, trifluoromethyl, cyano and amino; 1- or 2-naphthyl; 9-anthracenyl; 2-anthraquinonyl; unsubstituted or substituted pyridyl with a group selected from C1–C4 alkyl, C1–C4 alkoxy, cyano and halogen; 2-, 3- or 4-quinolinyl; oxiranyl; 1-benzotriazolyl; 2-benzoxazolyl; furanyl substituted with C1–C4 alkoxycarbonyl; C1–C4 alkylcarbonyl; or benzoyl, R1 represents halogen or C1–C4 alkyl, R2 and R3 represent independently hydrogen or C1–C4 alkyl, X represents oxygen atom, and Y represents oxygen atom, sulfur atom or carbonyl.

    摘要翻译： 本发明涉及下列通式（I）的嘧啶二酮衍生物，其可用作抗病毒剂，特别是作为治疗AIDS的药物，其药学上可接受的盐，其制备方法和含有该化合物的药物组合物，其中R代表环丙基; 环丁基 环己基 未取代的或具有选自羟基，C 1 -C 4 -C 4烷基，C 1 -C 3烷基的单 - ，二 - 或三取代苯基， 烷氧基，卤素，三氟甲基，氰基和氨基; 1-或2-萘基; 9-蒽基; 2-蒽醌; 未取代或取代的具有选自C 1 -C 4烷基，C 1 -C 4烷氧基的基团的吡啶基 ，氰基和卤素; 2-，3-或4-喹啉基; 环氧乙烷基 1-苯并三唑基; 2-苯并恶唑基; 被C 1 -C 4烷氧基羰基取代的呋喃基; C 1 -C 4烷基羰基; 或苯甲酰基，R 1表示卤素或C 1 -C 4烷基，R 2和R 2， 3独立地表示氢或C 1 -C 4烷基，X表示氧原子，Y表示氧原子，硫原子或羰基。

    Piperazine derivatives and process for the preparation thereof
    5.
    发明授权
    Piperazine derivatives and process for the preparation thereof 有权
    哌嗪衍生物及其制备方法

    公开(公告)号：US06683184B2

    公开(公告)日：2004-01-27

    申请号：US10105936

    申请日：2002-03-26

    申请人： Eui-Hwan Cho ,  Sun-Gan Chung ,  Sun-Hwan Lee ,  Ho-Seok Kwon ,  Dong-Wook Kang ,  Jeong-Ho Joo ,  Young-Hee Lee

    发明人： Eui-Hwan Cho ,  Sun-Gan Chung ,  Sun-Hwan Lee ,  Ho-Seok Kwon ,  Dong-Wook Kang ,  Jeong-Ho Joo ,  Young-Hee Lee

    IPC分类号： C07D40112

    CPC分类号： C07D213/74 ,  C07D213/75 ,  C07D241/20 ,  C07D295/215

    摘要： The present invention relates to a novel compound of formula (I) and its pharmaceutically acceptable acid addition salt, and process for the preparation thereof, which have strong antitumor activities and very low toxicity: wherein R1 and R2 are independently hydrogen, C1-C4 alkyl, C1-C4 alkylcarboxyl, C1-C4 alkylcarbonyl, C1-C4 alkoxy, C1-C4 hydroxyalkyl, C1-C4 aminoalkyl or C1-C4 hydroxyiminoalkyl, or R1 and R2 are fused to form C3-C4 unsaturated ring; R3, R4, R5, R6 and R7 are independently hydrogen, halogen, hydroxy, nitro, amino, C1-C4 alkyl, C1-C4 alkylcarboxyl, C1-C4 alkylcarbonyl, C1-C4 alkoxy, C1-C4 thioalkoxy; R8 is C1-C4 alkyl; Y is oxygen, sulphur, amino, subsitituted amino or C1-C4 thioalkyl; Z is C1-C4 alkoxy, C1-C4 alkyl, C1-C4 alkylamino or C1-C4 thioalkoxy; X1 and X2 are independently CH or nitrogen; and —N═C— and —C═Y— may form a single bond or a double bond provided that if —N═C— forms a single bond, —C═Y— forms a double bond, and if —C═Y— forms a single bond, —N═C— forms a double bond and R8 is nonexistent.

    摘要翻译： 本发明涉及一种新的式（I）化合物及其药学上可接受的酸加成盐及其制备方法，其具有强的抗肿瘤活性和极低的毒性：其中R1和R2独立地为氢，C1-C4烷基 ，C1-C4烷基羧基，C1-C4烷基羰基，C1-C4烷氧基，C1-C4羟基烷基，C1-C4氨基烷基或C1-C4羟基亚氨基烷基，或R1和R2稠合形成C3-C4不饱和环; R3，R4，R5 ，R6和R7独立地是氢，卤素，羟基，硝基，氨基，C1-C4烷基，C1-C4烷基羧基，C1-C4烷基羰基，C1-C4烷氧基，C1-C4硫代烷氧基; R8是C1-C4烷基; Y是氧，硫，氨基，取代的氨基或C1-C4硫代烷基; Z是C1-C4烷氧基，C1-C4烷基，C1-C4烷基氨基或C1-C4硫代烷氧基; X1和X2独立地是CH或氮; 并且-N = C-和-C = Y-可以形成单键或双键，条件是如果-N = C-形成单键，则-C = Y-形成双键，并且如果-C = Y - 形成单键，-N = C-形成双键，R8不存在。

    9-aminoacridine derivatives and process for the preparation thereof
    8.
    发明授权
    9-aminoacridine derivatives and process for the preparation thereof 失效

    公开(公告)号：US06620936B2

    公开(公告)日：2003-09-16

    申请号：US09855530

    申请日：2001-05-16

    申请人： Eui-Hwan Cho ,  Sun-Gan Chung ,  Sun-Hwan Lee ,  Ho-Seok Kwon ,  Dong-Wook Kang ,  Jeong-Ho Joo

    发明人： Eui-Hwan Cho ,  Sun-Gan Chung ,  Sun-Hwan Lee ,  Ho-Seok Kwon ,  Dong-Wook Kang ,  Jeong-Ho Joo

    IPC分类号： C07D21910

    CPC分类号： C07D219/10 ,  Y02P20/55

    摘要： The present invention relates to new 9-aminoacridine derivatives of general formula (I), wherein A is hydrogen or (II) (wherein X is oxygen or sulfur, R1, R2, R3, R4 and R5 are independently hydrogen, halogen, nitro, amino, hydroxy, C1-C4 lower alkylhydroxy, C1-C4 lower alkylamino, C1-C8 alkyl, C1-C4 lower alkoxy or C1-C4 lower alkyloxycarbonyl and m and n are independently an integer of 0, 1 or 2), R6, R7, R8 and R9 are independently C1-C8 alkyl or C1-C4 lower alkoxy, and Y is hydrogen, amino, —N═CHR′(wherein R′ is hydrogen, benzyl, C1-C8 alkyl or C1-C6 lower alkylamino), (III) (wherein R″ is hydrogen, benzyl, C1-C8 alkyl or C1-C6 lower alkylamino, and R′″ is hydrogen, benzyl, C1-C8 alkyl or amino protecting group) or (IV) (wherein, X is as defined above, R1′, R2′, R3′, R4′ and R5′ are independently hydrogen, halogen, nitro, amino, hydroxy, C1-C4 lower alkylhydroxy, C1-C4 lower alkylamino, C1-C8 alkyl, C1-C4 lower alkoxy or C1-C4 lower alkylcarboxy, and q and r are independently an integer of 0, 1 or 2) or its pharmaceutically acceptable salt, and process for the preparation thereof.

    Piperazine derivatives and methods for the preparation thereof and compositions containing the same
    10.
    发明授权
    Piperazine derivatives and methods for the preparation thereof and compositions containing the same 失效
    哌嗪衍生物及其制备方法和含有它们的组合物

    公开(公告)号：US5780472A

    公开(公告)日：1998-07-14

    申请号：US676174

    申请日：1996-07-15

    申请人： Eui-Hwan Cho ,  Sun-Gan Chung ,  Joong-Ypoung Kim ,  Sun-Hwan Lee ,  Ho-Seok Kwon ,  Byung-Chul Kim ,  Jae-Myeong Kong ,  Jea-Eung Lee ,  Dong-Wook Kang

    发明人： Eui-Hwan Cho ,  Sun-Gan Chung ,  Joong-Ypoung Kim ,  Sun-Hwan Lee ,  Ho-Seok Kwon ,  Byung-Chul Kim ,  Jae-Myeong Kong ,  Jea-Eung Lee ,  Dong-Wook Kang

    IPC分类号： A61K31/00 ,  A61K31/44 ,  A61K31/495 ,  A61K31/496 ,  A61P35/00 ,  C07D213/38 ,  C07D213/40 ,  C07D213/64 ,  C07D213/75 ,  C07D215/22 ,  C07D401/12 ,  C07D401/14

    CPC分类号： C07D213/40 ,  C07D213/38 ,  C07D213/64

    摘要： The present invention relates to novel compound of the general formula(I) and acid addition salt thereof. ##STR1## wherein R.sub.1 and R.sub.2 are independently hydrogen, C.sub.1 -C.sub.8 alkyl or optionally substituted C.sub.3 -C.sub.6 membered cycloalkyl containing C.sub.3 -C.sub.8 ; R.sub.3, R.sub.4, R.sub.5, R.sub.6 and R.sub.7 are independently hydrogen, halogen, hydroxy, nitro, C.sub.1 -C.sub.4 lower ester, C.sub.1 -C.sub.4 lower alkyl, C.sub.1 -C.sub.4 lower alkoxy, aryl, arylalkoxy or unsaturated amine; l is an integer of 0-7; m and n are independently an integer of 0-1; W is carbon or nitrogen; X is oxygen, sulfur, optionally substituted imine; Y is nitrogen or oxygen; and Z is hydrogen, C.sub.1 -C.sub.8 alkoxy, aryloxy, C.sub.1 -C.sub.4 alkylamine, cycloamine containing N.sub.1 -N.sub.5 or oxo group. The present compounds of the above formula (I) has no only strong antimumor activities but lower toxicities, and accordingly are expected as novel antitumor agents.

    摘要翻译： PCT No.PCT / KR96 / 00005 Sec。 371日期：1996年7月15日 102（e）1996年7月15日PCT PCT 1996年1月10日PCT公布。 WO90 / 21648 PCT出版物 日期：1996年7月18日本发明涉及通式（I）的新型化合物及其酸加成盐。 （I）其中R1和R2独立地是氢，C1-C8烷基或含有C3-C8的任选取代的C3-C6元环烷基; R3，R4，R5，R6和R7独立地是氢，卤素，羟基，硝基，C1-C4低级酯，C1-C4低级烷基，C1-C4低级烷氧基，芳基，芳基烷氧基或不饱和胺; l是0-7的整数; m和n独立地为0-1的整数; W是碳或氮; X是氧，硫，任选取代的亚胺; Y是氮或氧; Z为氢，C1-C8烷氧基，芳氧基，C1-C4烷基胺，含有N1-N5的环胺或氧代基。 上述式（I）的本发明化合物不仅具有较强的抗肿瘤活性，而且具有较低的毒性，因此被认为是新的抗肿瘤剂。